Annual General Meeting 2020

Last modified: 22.5.2020

Annual General Meeting 2020

The Optomed Annual General Meeting will be held on Thursday, 11 June 2020 at 10.00 a.m. (EEST) at Life Science Center Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland.

In order to prevent the spread of the COVID-19 pandemic, the Annual General Meeting will be arranged so that a shareholder or his/her proxy presentative may not be present at the venue of the meeting. Shareholders may only participate in the Annual General Meeting and exercise their rights by voting in advance or through a proxy representative as well as by posing counterproposals and questions in advance.

Each shareholder, who is registered on the record date of the Annual General Meeting, on 1 May 2020, in the shareholders’ register of the Company maintained by Euroclear Finland Oy, has the right to participate in the Annual General Meeting. A shareholder whose shares are registered on his/her personal Finnish book-entry account is registered in the shareholders’ register of the Company. A shareholder may only participate in the Annual General Meeting by voting in advance or through a proxy representative in the manner described below as well as by posing counterproposals and questions in advance.

The registration period and advance voting period commence on 25 May 2020 at 9:00 a.m. (EEST), when the deadline for delivering counterproposals to be put to a vote has expired. A shareholder who is registered in the shareholders’ register of the Company and wants to participate in the Annual General Meeting by voting in advance, shall register for the meeting by giving a prior notice of participation and by delivering his/her votes in advance by no later than on 3 June 2020 at 4:00 p.m. (EEST), by which time the notice of participation and votes needs to have been received by the Company.

Shareholders with a Finnish book-entry account can register and vote in advance on certain matters on the agenda of the Annual General Meeting during the period beginning on 25 May 2020 at 9:00 a.m. (EEST) and ending on 3 June 2020 at 4:00 p.m. (EEST) in the following manners:

  • via this link (register for the Annual General Meeting)
  • A shareholder may deliver an advance voting form available on the Company’s website or corresponding information to Hannes Snellman Attorneys Ltd by regular mail to Hannes Snellman Attorneys Ltd, Yhtiökokous Optomed Oyj, Eteläesplanadi 20, FI-00130 Helsinki, Finland or by email to optomedagm2020@hannessnellman.com.

Please see additional information with regards to the Annual General Meeting in the meeting invitation. The instructions to register and vote for the nominee registered shareholders are also included in the invitation.

Counterproposals and questions

Shareholders who hold at least one hundredth of all the shares in the Company have the right to pose counterproposals concerning the matters on the agenda of the Annual General Meeting to be placed for a vote. Such counterproposals shall be delivered to the Company by email to sakari.knuutti@optomed.com at the latest by 22 May 2020 at 4:00 p.m. (EEST), by which time the counterproposals must be received by the Company. The shareholders shall in connection with the counterproposal present a statement of their shareholding in the Company. The counterproposal is admissible for consideration at the Annual General Meeting if the shareholders who have made the counterproposal have the right to attend the meeting and on the record date of the Annual General Meeting represent at least one hundredth of all shares in the Company. If a counterproposal will not be taken up for consideration at the Annual General Meeting, the votes given in favour of the counterproposal will not be taken into account. The Company will publish possible counterproposals to be put to a vote on the Company‘s website at www.optomed.com/annual-general-meeting-2020/ on 25 May 2020 at the latest.

A shareholder has the right to pose questions with respect to the matters to be considered at the meeting pursuant to Chapter 5, Section 25 of the Finnish Companies Act by email to sakari.knuutti@optomed.com or by regular mail to Optomed Plc, Life Science Center Keilaniemi, Keilaranta 16 B, FI-02150 Espoo, Finland at the latest by 28 May 2020 at 4:00 p.m. (EEST), by which time the questions must be received by the Company. Such questions by shareholders, responses to such questions by the Company‘s management in accordance with the Finnish Companies Act as well as other counterproposals than those put up to a vote are available on the Company‘s website at www.optomed.com/annual-general-meeting-2020/ on 1 June 2020 at the latest. As a prerequisite for presenting questions or counterproposals, a shareholder must present sufficient evidence to the Company of his/her shareholdings.

Material for the general meeting:

 

Register for the Annual General Meeting